Psychodermatology liaison clinic in India: a working model

Goyal, Nupur; Shenoi, Shrutakirthi D; Prabhu, Smitha; Sreejayan, K; Munoli, Ravindra N; Rai, Santosh

doi:10.1177/0049475517736708

Cited by 18 publications

(26 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…31 Psychopharmacological and psychotherapeutic interventions may enhance the psychological effects of dermatological diseases. 32,33 Studies investigating this aspect of the subject clearly indicate the adverse effects of low QoL on the treatment success and positive contribution of cognitive and behavioral therapy options. 34,35 The results of QoL assessments may provide important guidance for therapy options and evaluation of treatment efficacy.…”

Section: Discussionmentioning

confidence: 99%

“…Medical treatment nonadherence has been shown to be three times greater in depressed patients than in nondepressed ones 31 . Psychopharmacological and psychotherapeutic interventions may enhance the psychological effects of dermatological diseases 32,33 . Studies investigating this aspect of the subject clearly indicate the adverse effects of low QoL on the treatment success and positive contribution of cognitive and behavioral therapy options 34,35 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides

Engın

Keçici

Uzun

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Mycosis fungoides (MF) is a chronic disease, causing serious morbidities and mortality. This study was designed to measure depression and anxiety levels in MF patients, and quality of life (QoL) assessments and to compare the results with controls. Fifty-two patients with a diagnosis of MF and 52 age and sex matching healthy controls were enrolled in this study. Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and the 36-Item Short Form Health Survey (SF-36) were administered to all patients and controls. Mean BAI and BDI scores of the patients with MF were significantly higher than controls. In case of the SF-36, general health perception, emotional, and social functioning scores were significantly lower in MF patients. Depression scores of the patients' were positively correlated with the age of disease onset and negatively correlated with physical functioning scores. Significant negative correlation was detected between eight subscales of the SF-36 and BDI and BAI scores. This study has demonstrated that there is significant impairment of QoL in MF patients MF, with higher anxiety and depression levels, when compared to control group. As the disease progresses, level of depression increases and patients' general health perception deteriorates.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides

Engın

Keçici

Uzun

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…[12][13][14] Even though a psychodermatology liaison clinic model has been proposed by Indian dermatologists, the pharmacists' importance is often not considered; the latter's beliefs and attitudes could affect the care of patients with psychocutaneous disorders. 15 We conducted a study to understand the knowledge, attitudes and practices of pharmacists towards the prescription of psychotropic medications to dermatology patients. We also wanted to study the association between attitudes, behaviors and practices in these pharmacists.…”

Section: Introductionmentioning

confidence: 99%

Psychodermatology – a case for sensitization of pharmacists in Mumbai, India

Malkani¹,

Parekh²,

Karmakar³

et al. 2021

IJDVL

View full text Add to dashboard Cite

Background: Though studies have looked at the attitudes of dermatologists towards psychodermatology, few have highlighted the attitudes of pharmacists towards these conditions. Objectives: To study the knowledge, attitudes and practices of pharmacists towards the prescription of psychotropic medications to dermatology patients. Methods: This cross-sectional analysis included 80 pharmacists from Mumbai, India. We used an interviewer-administered questionnaire to collect information from pharmacists on their demographics, psychotropic medications in dermatological patients, knowledge about psychocutaneous conditions and comfort about dispensing these medications. Results: In our study, 37 (46%) of pharmacists received prescriptions of psychotropic drugs from dermatologists; however, 24 (30%) were not comfortable dispensing them. Sixty (75%) pharmacists felt that only psychiatrists should prescribe psychotropic drugs and 37 (46%) felt that they had a right to refuse to dispense prescribed medication; of these, 15 (19%) had actually refused to give medications to patients. Pharmacists who disagreed with the statement that 'the state of mind is associated with medical conditions', were more likely to discourage psychotropic prescription from dermatologists (29% vs 11%, P = 0.04). Pharmacists with experience of more than five years were significantly more likely to refuse to dispense medications (odds ratio: 5.14, 95% confidence interval: 1.02, 25.83; P = 0.047). Limitations: We did not have a list of all pharmacists in Mumbai; thus, no sampling frame could be applied. Conclusion: Pharmacists do comment on doctors’ prescriptions, discourage certain medications and even refuse to dispense them based on their personal opinions. Since they are the last stop for patients between the doctor and the medication, their inclusion (in addition to dermatologists, psychiatrists and psychologists) in integrated awareness, training and care programs would improve the quality of care of patients with psychocutaneous disorders.

show abstract

“…They may present as primary psychiatric disorders such as delusions of parasitosis (DP), dermatitis artefacta etc., or as chronic dermatoses such as atopic eczema or psoriasis, patients of which may have depression or anxiety secondary to their skin disease. In a study from Manipal,[ 1 ] 33% of the patients attending a psychodermatology liaison clinic had psychiatric co-morbidity. Since, psychological components contribute to the overall dermatological outcomes, managing them is of importance.…”

Section: Introductionmentioning

confidence: 99%